Atea Pharmaceuticals AVIR
NASDAQ AVIR
$5.21 +0.03 (+0.58%)
At close: Sep 30, 2026 · 4:00 PM EDT

Atea Pharmaceuticals (AVIR) Other financing activities (2025 - 2026)

Updated

Atea Pharmaceuticals' Other financing activities came in at $746,000 for Q1 2026, up 53.8% from $485,000 a year earlier.

Analysis

Atea Pharmaceuticals (AVIR) Other financing activities (2025 - 2026) Analysis & Trends

For FY2025, Atea Pharmaceuticals' Other financing activities was $485,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Atea Pharmaceuticals 417.87 Mn 417.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 746,000.00
Mar 31, 2025 485,000.00
API Access

Atea Pharmaceuticals Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AVIR&period=max&api_key=YOUR_API_KEY